These would deliver medication through the skin without traditional injections, potentially appealing to patients who prefer oral medications specifically to avoid needles but are frustrated by dosing requirements
The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
Two health issues that fit this type of description are hip and knee replacements

GLP-1 administration induces visceral illness in both rodents (Seeley et al., GLP-1R regulation of food reward In addition to being expressed in hypothalamic areas that regulate homeostatic feeding, the GLP-1R is expressed in areas that mediate food reward in both rodents (Merchenthaler et al., GLP-1R action on brown adipose tissue (BAT) thermogenesis In addition to causing changes in feeding, central GLP-1R activation may regulate body weight by increasing brown adipose tissue (BAT) thermogenesis (reviewed in Lockie et al., GLP-1R action on neuroprotection GLP-1R analogs have neuroprotective and anti-inflammatory properties, which may be contributing the beneficial effects on energy metabolism (reviewed in Holscher, Effectiveness of GLP-1R agonists on weight loss in humans Despite not have a complete understanding of the underlying molecular mechanisms, GLP-1R activation clearly has beneficial effects on both energy and glucose metabolism across a number of species

10.1074/jbc.272.36.22728